Pfizer confronts surge of lawsuits over Lipitor
(Reuters) - Pharmaceutical giant Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its blockbuster anti-cholesterol drug Lipitor but never properly warned the public. (Source: Reuters: Health)
Source: Reuters: Health - August 8, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

Atorvastatin protects against cerebral ischemia/reperfusion injury
(Neural Regeneration Research) In addition to its lipid-lowering effect, statins exert anti-inflammatory and antioxidant effects as well. Statins also provide protection against renal, pulmonary and myocardial ischemia/reperfusion injury. However, little evidence is available on similar changes in cerebral ischemia/reperfusion injury. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 4, 2014 Category: Global & Universal Source Type: news

NICE Lowers Risk Threshold for Starting StatinsNICE Lowers Risk Threshold for Starting Statins
The new guidelines are an update to the 2006 clinical recommendations and push for a more aggressive approach to patient management. Physicians should start treatment with atorvastatin in patients with a 10-year risk of cardiovascular disease that exceeds 10%. Heartwire (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 18, 2014 Category: Consumer Health News Tags: Cardiology News Source Type: news

'More adults should be taking statins,' says NICE
Conclusion Despite somewhat hysterical media coverage to the contrary ("millions more to be given statins," according to the Daily Express), nobody will be forced to take statins. If your GP does recommend statins, you should ask them to explain the benefits and risks for you personally of starting statin treatment. You may want to find out more about statins before making up your mind – the NHS Choices Health A-Z information on statins is a good place to start. If you do experience troublesome side effects while taking statins, contact your GP or the doctor in charge of your care. It could be the case that a...
Source: NHS News Feed - July 18, 2014 Category: Consumer Health News Tags: Heart/lungs Medication QA articles Source Type: news

Prices of 108 diabetes, cardiac formulations fixed: NPPA
The drugs that will become cheaper would include atorvastatin, gliclazide, glimepiride, heparin and metolazone among others. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 14, 2014 Category: Pharmaceuticals Source Type: news

Pharma’s statin fightback – or dilemma?
Are generic statins getting in the way of pharma’s plans? (Source: Alliance for Natural Health)
Source: Alliance for Natural Health - May 21, 2014 Category: Complementary Medicine Authors: Sophie Tags: Aseem Malhotra Astra Zeneca atorvastatin BMJ Catalyst: Heart Of The Matter cholesterol Cholesterol Treatment Trialists CTT Dr Malcolm Kendrick europe Health Insight UK international Jerome Burne John Abramson Lipitor NICE P Source Type: news

The Bell Law Firm Renews Investigations into Lipitor Injury Claims as...
The Charleston-based law firm continues to investigate claims of women who developed Type II diabetes after taking the cholesterol-lowering drug Lipitor as 56 cases are centralized into multidistrict...(PRWeb April 30, 2014)Read the full story at http://www.prweb.com/releases/bell-law-investigates/lipitor-injury-claims/prweb11811430.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 1, 2014 Category: Pharmaceuticals Source Type: news

US Food and Drug Administration okays safety of Indian medicines
The US drug regulator says it has detected no impurity in the Indian version of cholesterol-lowering generic drug Atorvastatin in recent tests. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 27, 2014 Category: Pharmaceuticals Source Type: news

Lipitor MDL Approved for Type 2 Diabetes Litigation: McSweeney /...
Federal litigation involving Pfizer's cholesterol-lowering drug Lipitor has been consolidated before a single judge in South Carolina.(PRWeb March 25, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11664980.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 26, 2014 Category: Pharmaceuticals Source Type: news

Statins aren't a wonder drug | Malcolm Kendrick
The claims made for statins are overblown. They are not a cure for most of the major diseases afflicting western civilisationStatins are the most widely prescribed drugs in medical history. They appear to have effortlessly conquered heart disease. If guidance proposed by Nice – the National Institute for Health and Care Excellence – is followed, 15 million people in the UK, most with no history of heart disease, could soon be taking them.A recent study by researchers at Imperial College London made the claim that "statins have virtually no side effects, with users experiencing fewer adverse symptoms than if they had ta...
Source: Guardian Unlimited Science - March 23, 2014 Category: Science Authors: Malcolm Kendrick Tags: Comment The Guardian World news Health Health policy Society Drugs UK news Statins Comment is free Source Type: news

Statins aren't a wonder drug | Malcolm Kendrick
This article was corrected on 24 March 2014. It originally said in the eighth paragraph: "Flecainide suppressed dangerous heart arrhythmias, but was pulled from the market for killing thousands of people." This has been amended, as the drug that was pulled from the market was encainide, not flecainide.StatinsDrugsHealthHealth policyMalcolm Kendricktheguardian.com © 2014 Guardian News and Media Limited or its affiliated companies. All rights reserved. | Use of this content is subject to our Terms & Conditions | More Feeds (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 23, 2014 Category: Science Authors: Malcolm Kendrick Tags: Statins Drugs Health Health policy Society UK news World news The Guardian Comment Comment is free Source Type: news

New statin guidelines would put half of U.S. adults on drugs
Guidelines have been criticized for overreach by suggesting medications such as Zocor and Lipitor for such a broad swath of U.S. population (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 19, 2014 Category: Consumer Health News Source Type: news

Alonso Krangle Applauds the Judicial Panel’s Creation of Lipitor MDL...
The United States Judicial Panel (USJP) on Multidistrict Litigation (MDL) has recently issued a transfer order that will remit 56 Lipitor lawsuits and many more tag-along actions to the District of...(PRWeb March 18, 2014)Read the full story at http://www.prweb.com/releases/2014/03/prweb11678193.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 18, 2014 Category: Pharmaceuticals Source Type: news

Generic atorvastatin recall applies to 90-count bottles of 10-mg tablets
Read the full story on MD Consult: Generic atorvastatin recall applies to 90-count bottles of 10-mg tablets (Source: MD Consult: News: Top Stories)
Source: MD Consult: News: Top Stories - March 13, 2014 Category: Journals (General) Source Type: news